BPA Call 36C24820A0022-36C24820N0836
Award Date
8/20/20
Potential Completion Date
10/24/20
Potential Value
$136K
Federal Agency
Veterans Integrated Service Network 8
Awardee
CSL Behring L.L.C.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
KNG OF PRUSSA, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VHA VISN 8) awarded CSL Behring L.L.C. a $117,050.64 potential value blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Government-Wide Acquisition Contract (FSS-61-IB). The BPA, described as a VISN WIDE BPA with no set-aside designation, is for the delivery of pharmaceutical products and has a completion date of August 20, 2020. Performance will take place in King of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded CSL Behring L.L.C. a blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract. The BPA call has a potential value of $25,213.77 and requires delivery of unspecified pharmaceutical or drug products to locations in King of Prussia, Pennsylvania under firm fixed price terms by April 30, 2020. No set-aside designation...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a blanket purchase agreement (BPA) call against the Pharmaceuticals and Drugs Federal Supply Schedule to CSL Behring L.L.C. for an estimated $136,441.88. The BPA, titled "VISN WIDE BPA," has a completion date of May 25, 2020 and was awarded on May 20, 2020. It utilizes firm fixed pricing and has no set-aside designation. The BPA was issued under the VHA's network-wide...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The contract, valued at $77,625.80, is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a ceiling value of $201,482,280 and is valid through September 2026. The awarded BPA call is for...
This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a foreign-owned, for-profit biotherapeutics company. The contract is for the supply of 5 gram vials of the immune globulin drug Privigen. The BPA call has a ceiling value of $84,903.00 and was awarded under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB), which has a total ceiling value of...
This federal contract award was issued by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The contract, valued at $84,601.40, is a Blanket Purchase Agreement (BPA) call under the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs. The contract provides for the delivery of various immune globulin products, including CARIMUNE, PRIVIGEN, and THROMBIN, to VA medical...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 21 (VISN 21) to CSL Behring L.L.C., a foreign-owned, for-profit pharmaceutical company, for an emergency drug purchase. The award, valued at $95,837.50, does not have a set-aside designation. CSL Behring holds several Indefinite Delivery Vehicles (IDVs) with the VA, including a Federal Supply Schedule contract for Pharmaceuticals and Drugs, a Blanket Purchase...
This federal contract award was issued by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. The $84,601.40 firm fixed-price contract is a Blanket Purchase Agreement (BPA) call under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The award provides for the delivery of various immune globulin products, including CARIMUNE, PRIVIGEN, and HAEGARDA, to support healthcare services for veterans. The...
This federal contract award, valued at $84,601.40, was made by the U.S. Department of Veterans Affairs (VA) to CSL Behring L.L.C., a global biotherapeutics company specializing in plasma-derived and recombinant therapies. The award is a Blanket Purchase Agreement (BPA) call under CSL Behring's existing Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The contract provides for the delivery of various immune globulin products, including CARIMUNE (6 grams and 12...
This Blanket Purchase Agreement (BPA) call was awarded under the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 8's (VISN 8) master GSA Schedule contract for pharmaceuticals and drugs. CSL Behring L.L.C. will deliver $25,227.62 worth of Privigen 675A00060, a human plasma-derived intravenous immunoglobulin product, on a firm fixed price basis to locations in King of Prussia, Pennsylvania. No set-aside designation was applied to this BPA call issued under the VA's...